Intravenous Clopidogrel (MDCO-157) Compared with Oral Clopidogrel: The Randomized Cross-Over AMPHORE Study.

about

A Safety Evaluation of Cangrelor in Patients Undergoing PCI.

P2860

Q38672923-F4B12352-7D55-4899-8BCE-D140844FB539

P2860

Intravenous Clopidogrel (MDCO-157) Compared with Oral Clopidogrel: The Randomized Cross-Over AMPHORE Study.

Item

http://www.wikidata.org/entity/Q38403462

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Intravenous Clopidogrel (MDCO- ...... ized Cross-Over AMPHORE Study.

@en

type

Item

label

Intravenous Clopidogrel (MDCO- ...... ized Cross-Over AMPHORE Study.

@en

prefLabel

Intravenous Clopidogrel (MDCO- ...... ized Cross-Over AMPHORE Study.

@en

P1476

Intravenous Clopidogrel (MDCO- ...... ized Cross-Over AMPHORE Study.

@en

P2093

Delphine Brugier

http://www.w3.org/2001/XMLSchema#string

Edith Guilloux

http://www.w3.org/2001/XMLSchema#string

Ghalia Anzaha

http://www.w3.org/2001/XMLSchema#string

Jayne Prats

http://www.w3.org/2001/XMLSchema#string

Jean-Philippe Collet

http://www.w3.org/2001/XMLSchema#string

Johanne Silvain

http://www.w3.org/2001/XMLSchema#string

Kan He

http://www.w3.org/2001/XMLSchema#string

Ming-yi Hu

http://www.w3.org/2001/XMLSchema#string

Nathalie Nicolas

http://www.w3.org/2001/XMLSchema#string

Sophie Galier

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necro

Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data.

High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2).

Effect of platelet inhibition with cangrelor during PCI on ischemic events.

Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.

Novel antiplatelet agents in acute coronary syndrome.

Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction.

Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis.

Pharmacokinetics and platelet aggregation inhibitory effects of a novel intravenous formulation of clopidogrel in humans.

New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis.

P2888

s40256-015-0145-0

P304

43-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40256-015-0145-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gilles Montalescot

Joe-Elie Salem

Jean-Sébastien Hulot

Christian Funck-Brentano

P577

2015-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282046109

http://www.w3.org/2001/XMLSchema#string

P6179

1009649454

http://www.w3.org/2001/XMLSchema#string

P698

26386578

http://www.w3.org/2001/XMLSchema#string

P921

clopidogrel

Intravenous Clopidogrel (MDCO-157) Compared with Oral Clopidogrel: The Randomized Cross-Over AMPHORE Study.

about

P2860

P2860

Intravenous Clopidogrel (MDCO-157) Compared with Oral Clopidogrel: The Randomized Cross-Over AMPHORE Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P921